Can we predict local recurrence in breast conserving surgery after neoadjuvant chemotherapy?

I. Cebrecos , O. Córdoba , J. Deu , J. Xercavins , I.T. Rubio

One of the benefits of neoadjuvant chemotherapy (NAC) is its ability to convert patients ineligible for breast conservative treatment (BCT) to be candidates for this treatment, although questions have been raised regarding the effectiveness of BCT in terms of loco-regional recurrence (LRR). The objective of this study is to evaluate LRR in this group and the influence of tumor characteristics in recurrence.

Mots clés: breast cancer; neoadjuvant therapy; conservative surgery; local recurrence; loco-regional recurrence

I. Cebrecos, O. Córdoba, J. Deu, J. Xercavins, I.T. Rubio. Can we predict local recurrence in breast conserving surgery after neoadjuvant chemotherapy?. EJSO - European Journal of Surgical Oncology, 2010, 36 (6), pp.528. ⟨10.1016/j.ejso.2010.04.004⟩. ⟨hal-00599227⟩